Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study

Mulugeta Tarekegn Angamo, Belete Habte Melese, Wubeante Yenet Ayen, Mulugeta Tarekegn Angamo, Belete Habte Melese, Wubeante Yenet Ayen

Abstract

Background: Good glycemic control reduces the risk of diabetic complications. Despite this, achieving good glycemic control remains a challenge in diabetic patients. The objective of this study is to identify determinants of glycemic control among insulin treated diabetic patients at Jimma University Hospital, Southwest Ethiopia.

Methods: Hospital-based cross-sectional study was conducted on systematically sampled 284 insulin-treated diabetic patients with a regular follow up. Data was collected by interviewing patients during hospital visits and reviewing respective databases of September 2010 to December 2011. Data collection took place from February 20 to May 20, 2012. Poor glycemic control was defined as fasting blood sugar (FBS) ≥126 mg/dL. Binary logistic regression analysis was conducted to identify predictors of poor glycemic control.

Results: Patients had a mean age of 41.37 (±15.08) years, 58.5% were males, the mean duration of insulin treatment was 4.9 (±5.1) years, 18.3% achieved good glycemic control (FBS≤126 mg/dL), 95% self-reported repeated use of disposable insulin syringe-needle and 48% correctly rotating insulin injection sites. Most (83.1%) of study participants had one or more complications. On multivariable logistic regression analyses, body weight of >70 Kg (AOR = 0.21; P<0.001), total daily dose of insulin ≤35 IU/day (AOR = 0.26; P<0.001), total daily dose variation without checking glycemic level (AOR = 3.39; P = 0.020), knowledge deficit about signs and symptoms of hyperglycemia (AOR = 3.60; P = 0.004), and non-adherence to dietary management (AOR = 0.35; P = 0.005) were independent predictors of poor glycemic control.

Conclusions: The proportion of patients with poor glycemic control was high, which resulted in the development of one or more complications regardless of duration on insulin treatment. Hence, appropriate management of patients focusing on the relevant associated factors and independent predictors of poor glycemic control would be of great benefit in glycemic control.

Conflict of interest statement

Competing Interests: The authors declare that they have no competing interests.

References

    1. Mooradian A (2003) Cardiovascular disease in type II diabetes mellitus: current management guidelines. Arch Intern Med 163: 33–40.
    1. IDF (2012) Diabetes atlas, 5th ed. via : Accessed 2012 November 20.
    1. Akbar D, Al-Gamdi A (2000) Common causes of admission in diabetics. Saudi Med J 21: 539–542.
    1. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al. (2005) Patient adherence improves glycemic control. Diabetes Educ 31: 240–250.
    1. Wallace TM, Matthews DR (2000) Poor glycemic control in Type 2 diabetes, conspiracy of disease, suboptimal therapy and attitude. Q J Med 93: 369–374.
    1. Devries JH, Snoek FJ, Heine RJ (2004) Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem. Diabet Med 21: 1263–1268.
    1. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, et al. (1998) Factors associated with glycemic control: A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 21: 71146–71153.
    1. Davies ML (2004) The reality of glycaemic control in insulin treated diabetes: Defining the clinical challenges. Int J Obesity 28: 14–22.
    1. Ramchandani N, Cantey-Kiser JM, Alter CA, Brink SJ, Yeager SD, et al. (2000) Self-reported factors that affect glycemic control in college students with type 1 diabetes. Diabetes Educ 26: 656–666.
    1. Dawit W, Leja H, Kifle W (2010) Patterns of diabetic complications at Jimma University Specialized Hospital, southwest Ethiopia. Ethiopian J Health Sci 20: 33–39.
    1. Gudina EK, Amade ST, Tesfamichael FA, Ram R (2011) Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia. BMC Endocrine Disorders 11 doi:.
    1. Behan KJ (2011) New American Diabetes Association guidelines for diagnosis, screening of diabetes. Adv Adm Lab 20: 22.
    1. Ahmed AT, Karter AJ, Warton EM, Doan JU, Weisner CM (2007) The relationship between alcohol consumption and glycemic control among patients with diabetes: The Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 23: 275–282.
    1. Chaturvedi N, Stephenson JM, Fuller JH (1995) The relationship between smoking and microvascular complications in the EURODIAB IDDM complications study. Diabet Care 18: 785–792.
    1. Stephen RB, Regina F, Athena PT, Ming J (2005) Predictors of glycemic control among patients with Type II diabetes: A longitudinal study. BMC Public Health 5: 1–9.
    1. Cai X, Han X, Luo Y, Ji L (2012) Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment. PLoS ONE 7: e38962 doi:.
    1. Maysaa K, Yousef SK, Abdelkarim Al-K, Kamel A (2010) Factors associated with poor glycemic control among patients with Type II diabetes. J Diabetes Complicat 24: 84–89.
    1. Adham M, Sivarajan FE, Batieha A, Ajlouni K (2010) Glycemic control and its associated factors in type II diabetic patients in Amman, Jordan. East Mediterr Health J 16: 732–739.
    1. Zeinab G, Shamsaddin N, Fazlollah G, Bagher L, Hamid Agha-A, et al. (2010) Determinants of glycemic control in female diabetic patients: A study from Iran. Lipids Health Dis 9: 1–5.
    1. Ashwin K, Shivaprakash G, Prabha A (2011) Body mass index and Waist circumference in Type II Diabetes mellitus patients attending a diabetes clinic. Int J Biol Med Res 12: 636–638.
    1. Barnard K, Batch BC, Lien LF (2011) Subcutaneous insulin; A Guide for dosing regimens in the hospital, department of medicine, division of endocrinology, metabolism, and nutrition, Duke University Medical Centre, Durham, USA. In: Lien LF, Cox ME, Feinglos MN, Corsino L, editors. Glycemic control in hospitalized patients. USA: Springer. pp. 250.
    1. Syed SH, Mohammad A (2003) Risk factors, knowledge and health status in diabetic patients. Saudi Med J 24: 1219–1224.
    1. Al-Sultan FA, Al-Zanki N (2005) Clinical epidemiology of Type II diabetes mellitus in Kuwait. Kuwait Med J 37: 98–104.
    1. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S (2006) Prevalence of inadequate glycemic control among patients with Type II diabetes in the United Kingdom general practice research data base: A series of retrospective analysis of data from 1998 through 2002. Clin Ther 28: 388–395.
    1. Vardar B, Kizilci S (2007) Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract 77: 231–236.
    1. Omar M, El-Kafoury A, El-Araby R (2011) Lipohypertrophy in children and adolescents with type I diabetes and the associated factors. BMC Research Notes 4: 1–3.
    1. Hauner H, Stockamp B, Haastert B (1996) Prevalence of lipohypertrophy in insulin treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes 104: 106–110.
    1. Misnikova IV, Dreval AV, Gubkina VA, Rusanova EV (2011) The Risks of repeated use of insulin pen needles in patients with Diabetes Mellitus. J Diabetes 1: 1–5.
    1. Johansson U-B, Amsberg S, Hannerz L, Wredling R, Adamson U, et al. (2005) Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care 28: 2025–2027.
    1. de Villiers FP (2005) Lipohypertrophy: a complication of insulin injections. S Afr Med J 95: 858–859.
    1. Zhaolan L, Chaowei F, Weibing W, Biao X (2010) Prevalence of chronic complications of type II diabetes mellitus in outpatients. Health Qual Life Out 8: 1–9.
    1. Angelos AP, Nick K, Aristidis F, Emmanuel I, Dimitris N (2007) Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health 7: 186–189.
    1. Snoek FJ (2002) Breaking the barriers to optimal glycaemic control: What physicians need to know from patients' perspectives. Int J Clin Pract Suppl 129: 80–84.
    1. Collins MM, Bradley CP, O'Sullivan T, Perry IJ (2009) Self-care coping strategies in people with diabetes: a qualitative exploratory study. BMC Endocrine Disorders 9 doi:.
    1. Jiang J, Qiu H, Zhao G, Zhou Y, Zhang Z, et al. (2012) Dietary fiber intake is associated with HbA1c level among prevalent patients with type 2 diabetes in Pudong new area of Shanghai, China. PLoS ONE 7: e46552 doi:.
    1. Vimalavathini R, Gitanjali B (2009) Effect of temperature on the potency & pharmacological action of insulin. Indian J Med Res 130: 66–169.
    1. Vimalavathini R, Agarwal SM, Gitanjali B (2008) Educational program for patients with type-I diabetes mellitus receiving free monthly supplies of insulin improves knowledge and attitude, but not adherence. Int J Diab Dev Countries 28: 86–90.
    1. Lind M, Oden A, Fahlén M, Eliasson B (2009) The true value of HbA1c as a predictor of diabetic complications: Simulations of HbA1c variables. PLoS ONE 4: e4412 doi:.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe